Theravance Biopharma, Inc. (TBPH)

18.17 +0.49 (+2.77%) USD  |  NASDAQ  |  Dec 12, 16:00
18.68 +0.51 (+2.81%) Pre-Market: 08:34
More

Theravance Biopharma Cash and Short Term Investments (Quarterly): 329.68M for Sept. 30, 2025

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. 421.68M
Assertio Holdings, Inc. 93.43M
Skye Bioscience, Inc. 35.31M
FibroGen, Inc. 117.98M
VYNE Therapeutics, Inc. 32.70M